The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era

Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases

(2013) L. J. Costa et al.   BLOOD

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States

(2012) Chadi Nabhan et al.   CANCER

Chronic lymphocytic leukemia in African Americans

(2012) Catherine C. Coombs et al.   LEUKEMIA & LYMPHOMA

Lymphoid Malignancies in U.S. Asians: Incidence Rate Differences by Birthplace and Acculturation

(2011) C. A. Clarke et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States

(2011) Pareen J. Shenoy et al.   Clinical Lymphoma Myeloma & Leukemia

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions

(2010) J. J. Turner et al.   BLOOD

The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect

(2010) S.-J. Wu et al.   BLOOD

Measuring cancer survival in populations: relative survival vs cancer-specific survival

(2010) D. Sarfati et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

(2010) William G. Wierda et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

(2010) Tadeusz Robak et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897

(2009) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study

(2009) Theresa H.M. Keegan et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

(2009) Wolfgang U. Knauf et al.   JOURNAL OF CLINICAL ONCOLOGY

Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group

(2009) Kathy S. Albain et al.   JNCI-Journal of the National Cancer Institute

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort

(2009) M.D. Seftel et al.   LEUKEMIA RESEARCH

Association of Insurance with Cancer Care Utilization and Outcomes

(2008) E. Ward et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis

(2008) Michael T Halpern et al.   LANCET ONCOLOGY